Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;113(11):2378-2383.
doi: 10.1111/apa.17415. Epub 2024 Sep 3.

Neurodevelopmental outcomes following paracetamol use for treatment of patent ductus arteriosus: A review

Affiliations
Review

Neurodevelopmental outcomes following paracetamol use for treatment of patent ductus arteriosus: A review

Adam Pearce et al. Acta Paediatr. 2024 Nov.

Abstract

Aim: Concerns exist regarding potential adverse neurodevelopmental outcomes associated with paracetamol exposure during pregnancy and early infancy. This review evaluates the evidence for the impact of paracetamol use for patent ductus arteriosus (PDA) treatment on neurodevelopmental outcomes in preterm infants.

Methods: A literature search was performed via Medline, Ovid Embase and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases. The search details are below: ('Infant, Newborn' [MeSH] OR 'neonate*' [Title/Abstract]) AND ('Paracetamol' [MeSH] OR 'Acetaminophen' [Title/Abstract]) AND ('Ductus Arteriosus, Patent/drug therapy' [MeSH] OR 'patent ductus arteriosus' [Title/Abstract]) AND ('Neurodevelopmental Disorders' [MeSH] OR 'neurodevelopment*' [Title/Abstract] OR 'Child Development' [MeSH] OR 'Developmental Disabilities' [MeSH]). All studies were critically appraised and synthesised.

Results: Seven studies reported neurodevelopmental outcomes after paracetamol use for PDA treatment in preterm infants <32 weeks gestation. The studies varied in dosage, route, and duration of paracetamol administration and in the methods used to assess neurodevelopmental outcomes. None of the studies revealed different outcomes between paracetamol-exposed preterm infants and controls.

Conclusion: Current low-to-moderate quality evidence suggests no association between paracetamol used for PDA treatment and adverse neurodevelopmental outcomes in preterm infants. Future well-powered studies with standardised neurodevelopmental assessments are warranted to strengthen the current evidence base.

Keywords: Bayley scales; acetaminophen; low‐birth‐weight infants; neurotoxicity; preterm infants.

PubMed Disclaimer

References

REFERENCES

    1. Mukherjee A, Jadhav V, Gupta A. Off‐label use of paracetamol in managing patent ductus arteriosus across neonatal intensive care units in the UK. Arch Dis Child Fetal Neonatal Ed. 2021;106(1):113‐114. doi:10.1136/archdischild-2020-320207
    1. Katsaras DN, Katsaras GN, Chatziravdeli VI, et al. Comparative safety and efficacy of paracetamol versus non‐steroidal anti‐inflammatory agents in neonates with patent ductus arteriosus: a systematic review and meta‐analysis of randomized controlled trials. Br J Clin Pharmacol. 2022;88(7):3078‐3100. doi:10.1111/BCP.15291
    1. Vlenterie R, Wood ME, Brandlistuen RE, Roeleveld N, van Gelder MMHJ, Nordeng H. Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study. Int J Epidemiol. 2016;45:1998‐2008. doi:10.1093/ije/dyw192
    1. Golding J, Gregory S, Clark R, Ellis G, Iles‐Caven Y, Northstone K. Associations between paracetamol (acetaminophen) intake between 18 and 32 weeks gestation and neurocognitive outcomes in the child: a longitudinal cohort study. Paediatr Perinat Epidemiol. 2020;34(3):257‐266. doi:10.1111/ppe.12582
    1. Bertoldi AD, Rifas‐Shiman SL, Boing AC, et al. Associations of acetaminophen use during pregnancy and the first year of life with neurodevelopment in early childhood. Paediatr Perinat Epidemiol. 2020;34(3):267‐277. doi:10.1111/ppe.12632

MeSH terms

LinkOut - more resources